Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹199Cr
Rev Gr TTM
Revenue Growth TTM
-6.36%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

VIRINCHI
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -7.0 | 6.0 | -8.2 | -8.4 | -4.2 | -6.0 | 2.4 | 13.6 | -7.7 | 5.6 | -16.8 | -6.7 |
| 43 | 50 | 50 | 44 | 47 | 54 | 50 | 56 | 52 | 54 | 51 | 51 |
Operating Profit Operating ProfitCr |
| 45.0 | 37.2 | 30.5 | 39.9 | 37.6 | 28.8 | 32.4 | 32.4 | 24.4 | 32.7 | 17.1 | 33.4 |
Other Income Other IncomeCr | 1 | 0 | 1 | 0 | 4 | 1 | 0 | 0 | 6 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 11 | 11 | 10 | 11 | 11 | 10 | 10 | 9 | 10 | 9 | 8 | 8 |
Depreciation DepreciationCr | 11 | 15 | 13 | 14 | 12 | 13 | 13 | 16 | 14 | 14 | 14 | 14 |
| 15 | 4 | 0 | 5 | 8 | 0 | 2 | 2 | -1 | 3 | -12 | 4 |
| 3 | -1 | -1 | 0 | 6 | -1 | 1 | -2 | 3 | 3 | 2 | 3 |
|
Growth YoY PAT Growth YoY% | 395.5 | 343.6 | 141.5 | -6.3 | -83.2 | -76.2 | -88.4 | -33.1 | -317.6 | -64.8 | -8,141.2 | -56.9 |
| 15.6 | 5.5 | 2.0 | 7.7 | 2.7 | 1.4 | 0.2 | 4.5 | -6.4 | 0.5 | -22.1 | 2.1 |
| 1.5 | 0.5 | 0.2 | 0.6 | 0.2 | 0.1 | 0.0 | 0.4 | -0.4 | 0.0 | -1.3 | 0.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 22.8 | 57.3 | 31.3 | 19.1 | 19.2 | -6.3 | -7.2 | 2.8 | -14.3 | -3.8 | 0.4 | -4.6 |
| 117 | 187 | 223 | 246 | 287 | 271 | 258 | 264 | 206 | 191 | 212 | 208 |
Operating Profit Operating ProfitCr |
| 15.9 | 14.3 | 22.3 | 28.1 | 29.5 | 29.0 | 27.0 | 27.4 | 34.0 | 36.4 | 29.6 | 27.5 |
Other Income Other IncomeCr | 2 | 2 | 2 | 1 | 4 | 2 | 11 | 3 | 4 | 5 | 7 | 7 |
Interest Expense Interest ExpenseCr | 2 | 3 | 12 | 18 | 22 | 22 | 32 | 26 | 33 | 43 | 39 | 35 |
Depreciation DepreciationCr | 11 | 12 | 25 | 33 | 36 | 45 | 48 | 48 | 56 | 54 | 55 | 56 |
| 11 | 18 | 30 | 46 | 66 | 46 | 22 | 28 | 21 | 17 | 2 | -6 |
| 3 | 2 | 6 | 13 | 7 | -1 | 19 | 14 | 8 | 4 | 2 | 10 |
|
| 113.8 | 95.5 | 45.6 | 40.0 | 78.4 | -21.1 | -94.3 | 428.2 | -9.9 | 6.0 | -96.4 | -3,434.0 |
| 6.0 | 7.4 | 8.2 | 9.7 | 14.5 | 12.2 | 0.8 | 3.9 | 4.1 | 4.5 | 0.2 | -5.6 |
| 2.3 | 4.5 | 4.4 | 5.8 | 9.4 | 7.1 | 0.3 | 1.8 | 1.6 | 1.5 | 0.1 | -1.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 18 | 18 | 27 | 28 | 31 | 33 | 37 | 79 | 84 | 94 | 103 | 103 |
| 89 | 106 | 180 | 221 | 281 | 341 | 338 | 292 | 314 | 353 | 373 | 359 |
Current Liabilities Current LiabilitiesCr | 24 | 48 | 83 | 116 | 104 | 88 | 100 | 100 | 114 | 137 | 123 | 113 |
Non Current Liabilities Non Current LiabilitiesCr | 19 | 93 | 128 | 122 | 114 | 104 | 212 | 233 | 266 | 260 | 250 | 259 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 46 | 86 | 89 | 153 | 148 | 157 | 173 | 195 | 206 | 209 | 183 | 192 |
Non Current Assets Non Current AssetsCr | 104 | 178 | 329 | 341 | 387 | 410 | 514 | 509 | 581 | 642 | 664 | 640 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 12 | 23 | 79 | 35 | 81 | 85 | 50 | 82 | 127 | 116 | 84 |
Investing Cash Flow Investing Cash FlowCr | -3 | -94 | -126 | -51 | -83 | -68 | -154 | -34 | -137 | -114 | -78 |
Financing Cash Flow Financing Cash FlowCr | 2 | 73 | 31 | 14 | 1 | -17 | 115 | -31 | 4 | -13 | -19 |
|
Free Cash Flow Free Cash FlowCr | 9 | -70 | -46 | -15 | -3 | 17 | -12 | 50 | -9 | 3 | 5 |
| 139.2 | 141.2 | 334.2 | 106.6 | 137.6 | 183.5 | 1,865.2 | 581.9 | 1,002.0 | 863.2 | 17,347.4 |
CFO To EBITDA CFO To EBITDA% | 52.1 | 73.5 | 123.5 | 36.7 | 67.5 | 77.1 | 52.2 | 82.4 | 120.0 | 106.7 | 94.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 34 | 59 | 310 | 291 | 257 | 86 | 129 | 463 | 314 | 288 | 214 |
Price To Earnings Price To Earnings | 4.1 | 3.6 | 13.1 | 8.8 | 4.3 | 1.9 | 47.0 | 32.4 | 24.3 | 21.0 | 297.6 |
Price To Sales Price To Sales | 0.3 | 0.3 | 1.1 | 0.8 | 0.6 | 0.2 | 0.4 | 1.3 | 1.0 | 1.0 | 0.7 |
Price To Book Price To Book | 0.3 | 0.5 | 1.5 | 1.2 | 0.8 | 0.2 | 0.3 | 1.3 | 0.8 | 0.6 | 0.5 |
| 1.8 | 4.6 | 7.2 | 4.6 | 3.4 | 2.1 | 3.9 | 7.0 | 5.7 | 5.5 | 5.6 |
Profitability Ratios Profitability Ratios |
| 99.9 | 99.9 | 97.9 | 96.5 | 94.2 | 93.8 | 93.5 | 92.4 | 93.7 | 95.3 | 95.3 |
| 15.9 | 14.3 | 22.3 | 28.1 | 29.5 | 29.0 | 27.0 | 27.4 | 34.0 | 36.4 | 29.6 |
| 6.0 | 7.4 | 8.2 | 9.7 | 14.5 | 12.2 | 0.8 | 3.9 | 4.1 | 4.5 | 0.2 |
| 9.6 | 9.1 | 11.2 | 15.6 | 18.6 | 12.8 | 8.4 | 8.4 | 7.5 | 7.8 | 5.4 |
| 7.7 | 13.1 | 11.4 | 13.3 | 18.9 | 12.4 | 0.7 | 3.8 | 3.2 | 3.0 | 0.1 |
| 5.5 | 6.1 | 5.7 | 6.7 | 11.0 | 8.2 | 0.4 | 2.0 | 1.6 | 1.6 | 0.1 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **1. Company Overview**
Founded in 1990 and headquartered in Hyderabad, India, **Virinchi Limited** is a diversified technology-led group operating at the intersection of **fintech, healthcare, IT services, and data science**. It leverages deep expertise in artificial intelligence, machine learning (ML), and digital platforms to create scalable, asset-light businesses across high-growth sectors.
The company is led by a team with strong academic credentials (IIT/IIM background) and operates through a portfolio of subsidiaries, balancing innovation with financial discipline. Over the years, it has evolved from an IT services firm into a multi-vertical organization with globally recognized products and services.
---
### **2. Core Business Verticals**
Virinchi operates four primary business segments, unified by shared technological foundations in AI, data analytics, and process automation:
#### **A. US Fintech (QFund – SaaS Platform)**
- **Product**: *QFund™*, a cloud-based SaaS platform for the US alternative finance industry, primarily serving subprime lending institutions.
- **Launch**: 2002; established as a market leader in micro-lending technology.
- **Market Position**: Processes ~450,000 loans/month, managing $3B+ in annual disbursements, across 18 licensed lenders in 45 U.S. states.
- **Clients**: Serves 4 of the top 5 alternative lenders in the U.S., with ~70% of IT revenue coming from clients with 8+ years of partnership.
- **FY24–25 Revenue**: ₹133.37 crore (69.9% of total IT revenue).
- **Key Highlights**:
- Transitioning to **multi-tenant SaaS architecture** powered by **agentic AI**, drastically reducing onboarding time and operational costs.
- **Pay-per-use model** aligns revenue with client adoption; strong customer retention and organic growth via referrals.
- Industry consolidation drives expansion—recently scaled operations for a major client post-acquisition.
- Exploring international replication (Canada) and plans to enter Indian and SME lending markets.
#### **B. Healthcare Services (Virinchi Hospitals)**
- **Flagship Facility**: 600-bed tertiary care hospital in Banjara Hills, Hyderabad (30-year lease), equipped with cutting-edge infrastructure:
- 11 modular OTs, 3T fMRI, 128-slice dual-energy CT, 130 ICU beds.
- Fully NABH-accredited with integrated HIS/EMR via acquired subsidiary *Asclepius Consulting & Technologies*.
- **Other Facilities**: Two smaller hospitals (Barkatpura & Hayathnagar), totaling 600 licensed beds.
- **Expansion Projects**:
- 100-bed oncology block in Banjara Hills (scheduled completion: March 2027).
- 300-bed multi-specialty hospital under construction in Visakhapatnam (expected FY2025–26).
- Near-term bed capacity outlook: **1,100 beds**; long-term goal: **5,000 beds**.
- **FY24–25 Performance**:
- Revenue: ₹104 crore (34.6% of total operating revenue).
- EBITDA Contribution: 27.7%, despite -12.5% YoY revenue growth due to strategic reinvestment.
- **Strategic Vision**:
- Evolve into **proactive, wellness-focused ecosystems** powered by predictive analytics.
- Target **1 billion patients** in a decade via a unified digital health platform.
- Expand into underserved eastern India and leverage telemedicine (omnichannel model) for scalable outreach.
- Innovations: Stem cell therapy for osteoarthritis (first in Telangana), transplants, and “Right to Science” partnerships with U.S., U.K., and Israeli institutions.
#### **C. Indian Fintech (vCard – Payment & Credit Services)**
- **Launch**: 2019; India’s **first mobile-based, UPI-linked "downloadable" credit card**.
- **Model**: Partners with banks and NBFCs (e.g., RBL Bank, Pinnacle Capital) to deliver credit to **underserved, low-income populations**.
- **Product Offerings**:
- **Credit Cards (Bank Partnership Model)**: Co-branded with banks; digital sub-limit of ₹20,000 via UPI app.
- **Digital Credit Line (NBFC Partnership)**: Instant approval (₹1,000–5,000); cash transfer + EMI conversion.
- **Technology**:
- AI-driven underwriting using PAN, Aadhaar, UPI spend, and GST data; assesses users **without CIBIL history**.
- One of the **lowest credit origination costs globally (~₹30/card)** due to digital, AI-powered workflows.
- PCI DSS compliant; uses Cashfree (payments), TransUnion (credit checks), and IDfy (eKYC).
- **User Engagement**:
- 1.2M+ app installs; 25,000+ cumulative customers; >₹80 crore UPI transactions processed.
- Active credit book: ₹20.56 crore; disbursements over $50 million.
- **FY24–25 Performance**:
- Revenue: ₹6.31 crore; EBIT loss ₹3.33 crore (investing phase).
- **Growth Strategy**:
- Scale through **new banking partnerships** after discontinuing a previous alliance for operational reasons.
- Aggressively target **debit card users and blue-collar workers** as credit adopters.
- Projected to become a **$1B revenue business within 5 years**, serving 600M+ underbanked Indians.
#### **D. IT & IDC Services (KSoft Systems Inc.)**
- **Subsidiary**: KSoft Systems Inc. (U.S.-based), operating since 2006.
- **Services**: Enterprise IT solutions in SMAC (Social, Mobility, Analytics, Cloud), ERP, data analytics, and custom application development.
- **Clients**: 90%+ in tech, telecom, and banking sectors; known for speed, scalability, and precision.
- **Infrastructure**:
- SOC-2 certified **data centers in California and Atlanta**.
- Developing third-party data center services; evaluating entry when commissioning costs per MW decline.
- **FY24–25 Performance**:
- Revenue: ₹57.30 crore; FY23–24 growth: 27.6%.
- EBIT: ₹18.59 crore (positive).
- **Client Model**: Onsite, offshore, hybrid delivery; 75-person U.S. team, 150+ offshore.
- **AI Integration**: Used across healthcare, fintech, and IT projects to improve efficiency, compliance, and customer experience.
---
### **3. Strategic Enablers**
- **Artificial Intelligence & Data Science**:
- Embedded across all verticals—AI drives credit scoring (vCard), reduces disbursement time (QFund), and enhances hospital operations (automated discharge summaries, scheduling).
- Subsidiary *Virinchi Combinatorics & Systems Biology* has mapped **95% of unexplored biological system dimensions**, signaling deep R&D capability.
- **Asset-Light Expansion**:
- Leverages long-term leases (e.g., 30-year hospital lease in super mall) to minimize capex and maintain a **low-debt, high-liquidity balance sheet**.
- Funds new ventures (e.g., data centers, fintech) using **annuity revenues from mature businesses** (QFund, IT services).
- **Synergistic Business Model**:
- Shared tech stack enables cross-vertical learning (e.g., U.S. credit models inform India’s vCard).
- Proprietary machine learning engines trained on over **28 million U.S. financial profiles**.
---
### **4. Key Financial & Operational Metrics (FY24–25)**
| Segment | Revenue (₹ Crore) | % of Total | EBITDA Contribution | Notes |
|----------------------------|-------------------|------------|----------------------|-------|
| QFund (US SaaS) | 133.37 | ~70% of IT rev | N/A | SaaS margin, pay-per-use model |
| Healthcare Services | 104.00 | 34.6% of total | 27.7% | Growth phase, -12.5% YoY revenue |
| IT & IDC Services (KSoft) | 57.30 | 30.1% of IT | Positive (₹18.59 Cr) | 27.6% YoY growth |
| vCard (India Fintech) | 6.31 | Segment loss | ₹-3.33 Cr | Pre-scaling investment phase |
> **Note**: The company’s diversified model has led to investor confusion; management acknowledges that **each vertical could command standalone valuation** if separated.
---
### **5. Recent Developments (2024–25)**
- **Healthcare**:
- Commissioned stem cell therapy programs; performing transplants across states.
- Preparing to launch oncology block in Hyderabad (2027) and new facility in Vizag.
- Expanding telemedicine footprint to Tier 2/3 cities.
- **Fintech**:
- Onboarding new banking partners to scale vCard; targeting 50,000+ customers in FY25–26.
- vCard platform enhances user experience with AI, EMI conversion, interest-free credit, and zero-touch support.
- **Technology**:
- Modernized UX for QFund; launched machine learning underwriting engine.
- Exploring multi-tenancy SaaS, AI integration, and automated client scaling.
- **Investor Confidence**:
- A long-term U.S. QFund client invested **$2M via convertible debentures** 30 months ago.
- **Global Expansion**:
- Incorporated **Virinchi Technologies Limited in Canada**, not yet operational.